ArticleThe Lancet regional health. Europe2025

Peptide receptor radionuclide therapy in G3 gastroenteropancreatic neuroendocrine tumors: a missed opportunity for European patients?

Francesco Panzuto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.